Stifel Initiates Coverage On Tectonic Therapeutic with Buy Rating, Announces Price Target of $75
Benzinga Newsdesk 6 months ago
NewsPrice TargetInitiationAnalyst Ratings
Stifel analyst James Condulis initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Buy rating and announces Price Target of $75.
Stifel analyst James Condulis initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Buy rating and announces Price Target of $75.